| P04 |
Newborn affected by noxious substances transmitted via placenta or breast milk |
| P04.0 |
Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery |
| P04.1 |
Newborn affected by other maternal medication |
| P04.11 |
Newborn affected by maternal antineoplastic chemotherapy |
| P04.12 |
Newborn affected by maternal cytotoxic drugs |
| P04.13 |
Newborn affected by maternal use of anticonvulsants |
| P04.14 |
Newborn affected by maternal use of opiates |
| P04.15 |
Newborn affected by maternal use of antidepressants |
| P04.16 |
Newborn affected by maternal use of amphetamines |
| P04.17 |
Newborn affected by maternal use of sedative-hypnotics |
| P04.18 |
Newborn affected by other maternal medication |
| P04.19 |
Newborn affected by maternal use of unspecified medication |
| P04.1A |
Newborn affected by maternal use of anxiolytics |
| P04.2 |
Newborn affected by maternal use of tobacco |
| P04.3 |
Newborn affected by maternal use of alcohol |
| P04.4 |
Newborn affected by maternal use of drugs of addiction |
| P04.40 |
Newborn affected by maternal use of unspecified drugs of addiction |
| P04.41 |
Newborn affected by maternal use of cocaine |
| P04.42 |
Newborn affected by maternal use of hallucinogens |
| P04.49 |
Newborn affected by maternal use of other drugs of addiction |
| P04.5 |
Newborn affected by maternal use of nutritional chemical substances |
| P04.6 |
Newborn affected by maternal exposure to environmental chemical substances |
| P04.81 |
Newborn affected by maternal use of cannabis |
| P04.89 |
Newborn affected by other maternal noxious substances |
| P04.9 |
Newborn affected by maternal noxious substance, unspecified |